The CDC said 117 MIS-C cases were reported in 2023, half of which required treatment in the intensive care unit. Of the 112 cases among patients eligible for the COVID-19 vaccine, 82% were among unvaccinated children, and of the 20 among vaccinated children, 60% of patients had waned in immunity at the time of their MIS-C illness.
MIS-C is a serious condition that typically occurs two to six weeks following a COVID-19 infection. Although incidents of it have decreased since its peak in late 2020 to early 2021, cases continue to occur. There was a relative rise in cases in fall 2023 that followed the increase in COVID-19 activity in the general population.
COVID-19 vaccination remains important to prevent MIS-C, the CDC said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
